Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel maleic diester route for 3-aminomethyltetrahydrofuran. High yield, low cost, scalable process for dinotefuran intermediates.
Novel enzymatic route for Dapoxetine intermediate ensures high purity and scalable production. Offers significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN101602656A details a high-yield hinokitiol synthesis using a novel toluene-based ring expansion system, offering significant cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN111303089B details a mild Mn-mediated trifluoromethylation. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable room temperature processes.
Novel one-step quinazolinone preparation method ensures high yield and purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost reduction and scalable production capabilities.
Novel preparation process ensures high purity 99 percent and low cost for pharmaceutical intermediates manufacturing supply chain efficiency and reliability
Patent CN104086624A reveals advanced HATU condensation for Carfilzomib. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110656148A details a novel biotransformation route for DHEA. This method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1206217C details a green synthesis of aziridines using ionic liquids, offering high cis-selectivity and catalyst reusability for cost-effective pharmaceutical intermediate manufacturing.
Novel rhodium-catalyzed route for ((1R,8S,9S,Z)-bicyclo[6.1.0]non-4-en-9-yl)methanol eliminates chromatography, offering scalable bioorthogonal chemistry solutions.
Patent CN107118143A reveals nickel-catalyzed synthesis offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN102816825A reveals a novel microbial fermentation route for DHEA from plant sterols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106701882A details a novel chemo-enzymatic route for UDCA production offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Patent CN117430526B details a high-purity synthesis method for cefixime side chain impurities ensuring reliable quality control and supply chain stability for pharmaceutical intermediates.
Patent CN106478515B reveals a novel method for Azilsartan intermediate synthesis, offering high purity and simplified workup for reliable pharmaceutical supply chains.
Patent CN104761600B reveals a glucose-derived catalyst enabling efficient Aldol reactions. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel three-step synthesis of Chrysin improves yield and purity. Cost-effective manufacturing solution for pharmaceutical intermediates supply chain.
Patent CN101652350B reveals a cost-effective iodide-mediated dehalogenation route for high-purity 2-haloimidazoles, enhancing supply chain reliability.
Discover the novel synthesis route for Macitentan intermediates disclosed in CN107162988B. Achieve higher purity and reduced costs by eliminating late-stage ethylene glycol purification.
Novel Pd/C water-based method for indole-2-carboxylic acid. Reduces cost, improves safety, ensures high purity for pharmaceutical supply chains.